Compass Therapeutics (CMPX) Revenue (2024)
Compass Therapeutics (CMPX) reported Revenue of $850000.0 for Q2 2024.
Compass Therapeutics (CMPX) Revenue (2024) Analysis & Trends
Compass Therapeutics (CMPX) has 1 years of Revenue data on file, last reported at $850000.0 in Q2 2024.
- For the quarter ending Q2 2024, Revenue changed N/A year-over-year to $850000.0; the trailing twelve-month figure through Jun 2025 stood at $850000.0 (changed 0.0% YoY), and the FY2024 full-year result was $850000.0, changed N/A from the prior year.
- Revenue was little changed at $850000.0 in Q2 2024.
- In the past five years, Revenue ranged from a high of $850000.0 in Q2 2024 to a low of $850000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Compass Therapeutics | 388.64 Mn | 193.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 850,000.00 |